March 7, 2025 - 05:55

Senate Democrats are set to introduce a comprehensive package of health policies as standalone legislation, which includes significant reforms targeting the pharmacy benefit manager (PBM) industry. This move comes after key health provisions were excluded from the December government spending bill, prompting lawmakers to seek alternative pathways to advance their healthcare agenda.
The proposed legislation aims to enhance transparency and accountability within the PBM sector, which plays a crucial role in managing prescription drug benefits for millions of Americans. By implementing these changes, Democrats hope to lower prescription drug costs and improve access to necessary medications for patients across the country.
In addition to PBM reforms, the new package may address various other health-related issues, reflecting the party's commitment to bolstering healthcare access and affordability. As the legislative session progresses, the introduction of this standalone bill underscores the Democrats' determination to prioritize health policy reforms, despite previous setbacks in broader spending negotiations.
October 8, 2026 - 18:55
New Jersey Grows Doula Training Network to 29 Approved ProgramsNew Jersey has expanded the number of doula training programs approved under NJ FamilyCare, bringing the total to 29 across the state. The move aims to widen access to doula support for residents...
October 8, 2026 - 04:20
Blue Cross Downcoding Practices Hit Behavioral Health Providers Across Several StatesBehavioral health providers in at least three states are dealing with downcoding actions from Blue Cross Blue Shield plans, according to reporting from BHB+. The issue involves claims being paid at...
October 7, 2026 - 04:49
Brooklyn Hospital Debuts Massive Mural Focused on Healing and ResilienceA new large-scale mural has transformed a busy corridor at a Brooklyn medical facility, turning a clinical passageway into a space that speaks to recovery, strength, and optimism. The artwork,...
October 6, 2026 - 12:29
The Case Against Approving a Flawed Multicancer Screening TestTelling more people they have cancer is not progress; progress is having fewer people die from cancer. That argument sits at the center of a growing debate over whether regulators should clear a...